We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+8.32%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$395M
AUM Growth
-$62.2M
Cap. Flow
-$70.5M
Cap. Flow %
-17.83%
Top 10 Hldgs %
40.77%
Holding
93
New
11
Increased
18
Reduced
29
Closed
19

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$8.57M
2
IMUX icon
Immunic
IMUX
+$5.02M
3
AMGN icon
Amgen
AMGN
+$4.6M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$4.28M
5
FULC icon
Fulcrum Therapeutics
FULC
+$3.65M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$18M
2
CRL icon
Charles River Laboratories
CRL
+$11.3M
3
ITMR
Itamar Medical Ltd. American Depository Shares
ITMR
+$7.96M
4
XLRN
Acceleron Pharma
XLRN
+$7.54M
5
NVRO
NEVRO CORP.
NVRO
+$5.93M

Sector Composition

Rank Sector Weight
1 Healthcare 97.83%
2 Industrials 0.81%
3 Technology 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STXS icon
51
Stereotaxis
STXS
$139M
$2.42M 0.61%
450,000
-229,082
-34% -$1.73M
VCYT icon
52
Veracyte
VCYT
$3.59B
$2.09M 0.53%
+45,000
New +$1.96M
TKNO icon
53
Alpha Teknova
TKNO
$397M
$2.02M 0.51%
+81,372
New +$1.74M
ALT icon
54
Altimmune
ALT
$570M
$1.98M 0.5%
175,000
-25,000
-13% -$304K
IRTC icon
55
iRhythm Holdings
IRTC
$4.13B
$1.9M 0.48%
+32,500
New +$1.72M
SURF
56
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1.88M 0.48%
248,267
+20,000
+9% +$128K
SDGR icon
57
Schrodinger
SDGR
$1.39B
$1.81M 0.46%
33,108
+2,500
+8% +$160K
SCTL
58
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$1.59M 0.4%
770,833
– –
BCRX icon
59
BioCryst Pharmaceuticals
BCRX
$2.71B
$1.47M 0.37%
101,961
-250,000
-71% -$3.94M
TELA icon
60
TELA Bio
TELA
$32.3M
$1.37M 0.35%
100,000
– –
ONCT
61
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$1.36M 0.34%
16,269
-4,500
-22% -$372K
ICAD
62
DELISTED
iCAD Inc
ICAD
$1.34M 0.34%
125,000
-406,255
-76% -$5.29M
BLRX
63
BioLineRX
BLRX
$11.7M
$1.13M 0.29%
10,277
-8,074
-44% -$958K
MNKD icon
64
MannKind Corp
MNKD
$1.24B
$1.11M 0.28%
255,047
-550,000
-68% -$2.48M
VCEL icon
65
Vericel Corp
VCEL
$2.29B
$993K 0.25%
20,340
– –
MTEM
66
DELISTED
Molecular Templates, Inc.
MTEM
$951K 0.24%
9,444
– –
CSLT
67
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$942K 0.24%
600,000
-77,734
-11% -$152K
ZYME icon
68
Zymeworks
ZYME
$1.77B
$871K 0.22%
+30,000
New +$997K
OPNT
69
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$772K 0.2%
+30,000
New +$536K
KRMD icon
70
KORU Medical Systems
KRMD
$152M
$645K 0.16%
226,256
+25,000
+12% +$82.7K
GYRE icon
71
Gyre Therapeutics
GYRE
$706M
$548K 0.14%
17,793
-34,667
-66% -$1.14M
VSTM icon
72
Verastem
VSTM
$629M
$541K 0.14%
14,650
+4,167
+40% +$153K
VERA icon
73
Vera Therapeutics
VERA
$2.16B
$445K 0.11%
25,638
-50,000
-66% -$894K
CALA
74
DELISTED
Calithera Biosciences, Inc
CALA
$219K 0.06%
5,031
– –
AUPH icon
75
Aurinia Pharmaceuticals
AUPH
$2.06B
– –
-49,969
Closed -$648K
1 2
3
4

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Parkman Healthcare Partners held 93 positions worth $395M, down 14% from $457M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Parkman Healthcare Partners withdrew a net $70.5M in Q3 2021, closing 19 positions and reducing 29 holdings. Its most notable exit was Intuitive Surgical, an estimated $18M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 96% a quarter earlier, followed by Industrials and Technology.

Against the trend, Parkman Healthcare Partners opened a new position in AbbVie worth $8.09M.

  • Parkman Healthcare Partners's largest Q3 2021 buy was AbbVie: 75,000 shares worth $8.09M.
  • Parkman Healthcare Partners added most to Immunic in Q3 2021, an estimated $5.02M increase.
  • Parkman Healthcare Partners's biggest Q3 2021 reduction was Charles River Laboratories, cutting an estimated $11.3M.
  • Parkman Healthcare Partners fully exited Intuitive Surgical in Q3 2021, selling an estimated $18M.
  • Parkman Healthcare Partners's ten largest holdings make up 41% of its $395M portfolio in Q3 2021.
  • Parkman Healthcare Partners opened 11 new positions and closed 19 in Q3 2021.
  • Parkman Healthcare Partners's portfolio value fell 14% quarter-over-quarter to $395M.

Based on Parkman Healthcare Partners's 13F filing for Q3 2021, filed 12 Nov 2021.